High Adenoma Detection Rates in Fecal Immunochemical Test-Based Colorectal Cancer Screening: Interim Results of the National Bowel Cancer Screening Program in Qatar

被引:0
|
作者
John, Anil K. [1 ]
Varughese, Betsy [1 ]
Abushaikha, Shaikha S. [2 ]
Hamdan, Ahed M. [3 ]
Pillai, Viswapriya [1 ]
Ayash, Ahmad M. [1 ]
Vincent, Paul K. [1 ]
Sultan, Khaleel [1 ]
Al Ejji, Khalid M. [1 ]
Singh, Rajvir [4 ]
Alabdulla, Samya [5 ]
Abdulmalik, Mariam [5 ]
Al Kaabi, Saad [1 ]
机构
[1] Hamad Med Corp, Gastroenterol & Hepatol, Doha, Qatar
[2] Primary Hlth Care Corp, Community Med, Doha, Qatar
[3] Primary Hlth Care Corp, Preventat Hlth Screening Programs, Doha, Qatar
[4] Hamad Med Corp, Heart Hosp, Cardiol Res, Doha, Qatar
[5] Primary Hlth Care Corp, Family Med, Doha, Qatar
关键词
crc; adenoma detection; bowel cancer screening; colorectal cancer; fecal immunochemical test; OCCULT BLOOD-TEST; QUALITY INDICATORS; COLONOSCOPY; PREVENTION; GUIDELINES; MORTALITY; WORLDWIDE; CRITERIA; SOCIETY;
D O I
10.7759/cureus.32274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Colorectal cancer is one of the most common cancers globally. Recent reductions in mortality rates have been primarily attributed to screening programs. The State of Qatar established a national bowel cancer screening program in 2016. Methodology: Fecal immunochemical testing (FIT) was used for average-risk individuals aged 50 to 74 years. Fecal immunochemical testing -positive participants were referred for total colonoscopy to detect polyps and cancers. Results: Among 32,751 FIT invitees, 11,130 took the test, and 758 (6%) of those were FIT positive. Of these, 375 (56.13%) participants underwent a colonoscopy, and polyps were detected in 198 (52.8%) and cancers in 19 (5.1%) participants. The adenoma detection rate exceeded 40%. Discussion and conclusion: The high yield of polyps and cancers in the screening program justifies an active, resource-intensive, and organized bowel cancer screening effort. The high adenoma detection rate in a FIT-based program warrants recalibration of target adenoma detection rates in screening programs.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer
    Zorzi, Manuel
    Hassan, Cesare
    Capodaglio, Giulia
    Baracco, Maddalena
    Antonelli, Giulio
    Bovo, Emanuela
    Rugge, Massimo
    ENDOSCOPY, 2020, 52 (10) : 871 - 876
  • [42] Fecal Hemoglobin Concentration Is Associated With the Risk of Colonoscopy Interval Cancers in a Fecal Immunochemical Test-Based Population Colorectal Cancer Screening
    Chiu, Han-Mo
    Lee, Yi-Chia
    Wu, Ming-Shiang
    GASTROENTEROLOGY, 2014, 146 (05) : S176 - S176
  • [43] Harm-to-Benefit Ratio of Fecal Immunochemical Test-Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations
    Toes-Zoutendijk, Esther
    van de Schootbrugge-vandermeer, Hilliene J.
    Katsara, Maria A.
    de Jonge, Lucie
    Spaander, Manon C. W.
    van Vuuren, Anneke J.
    van Kemenade, Folkert J.
    Dekker, Evelien
    Nagtegaal, Iris D.
    van Leerdam, Monique E.
    Lansdorp-Vogelaar, Iris
    Meester, Reinier G. S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (04)
  • [44] Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
    Manon van der Vlugt
    Beatriz Carvalho
    Joelle Fliers
    Nahid Montazeri
    Christian Rausch
    Esmée J Grobbee
    Manon van Engeland
    Manon C W Spaander
    Gerrit A Meijer
    Evelien Dekker
    World Journal of Gastrointestinal Oncology, 2022, 14 (11) : 2195 - 2207
  • [45] Time to Fecal Immunochemical Test Completion for Colorectal Cancer Screening
    Haas, Cameron B.
    Phipps, Amanda I.
    Hajat, Anjum
    Chubak, Jessica
    Wernli, Karen J.
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (04): : 174 - +
  • [46] Colonoscopy-Interval Colorectal Cancers in a National Colorectal Cancer Screening Program Based on Fecal Immunochemical Tests
    Lee, Chang Kyun
    Choi, Kui Son
    Eun, Chang Soo
    Park, Dongil
    Han, Dong Soo
    GASTROENTEROLOGY, 2016, 150 (04) : S448 - S449
  • [47] Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death
    Doubeni, Chyke A.
    Corley, Douglas A.
    Jensen, Christopher D.
    Levin, Theodore R.
    Ghai, Nirupa R.
    Cannavale, Kimberly
    Zhao, Wei K.
    Selby, Kevin
    Buckner-Petty, Skye
    Zauber, Ann G.
    Fletcher, Robert H.
    Weiss, Noel S.
    Schottinger, Joanne E.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [48] Adherence to Colorectal Cancer Screening: 4 Rounds of Fecal Immunochemical Test (FIT) Based Screening
    van der Vlugt, Manon
    Grobbee, Esmee J.
    Kuipers, Ernst J.
    Lansdorp-Vogelaar, Iris
    Essink-Bot, Marie-Louise
    Bossuyt, Patrick
    Spaander, Manon
    Dekker, Evelien
    GASTROENTEROLOGY, 2016, 150 (04) : S755 - S755
  • [49] Stable hemoglobin concentration with fecal immunochemical test at high temperatures in a Caribbean colorectal cancer screening program
    Blake, Shacara N.
    Kortlever, Tim L.
    Verbrugge, Sue Ellen
    van Vuuren, Anneke J.
    Dekker, Evelien
    van der Vlugt, Manon
    Hugtenburg, Jacqueline G.
    CLINICA CHIMICA ACTA, 2024, 560
  • [50] Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea
    Jun, Jae Kwan
    Sung, Na Young
    Song, Seung Hoon
    Hong, Seri
    Jang, Mi-Ae
    Song, Junghan
    Kim, Jeong-Ho
    Min, Won-Ki
    Lee, You Kyoung
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (03) : 249 - 254